Edition:
India

Deinove To Start Phase II Clinical Trial For DNV3837


Thursday, 16 May 2019 

May 16 (Reuters) - Deinove SA ::DEINOVE IS NOW READY TO START PHASE II CLINICAL TRIAL FOR ITS ANTIBIOTIC COMPOUND DNV3837.PRODUCTION OF FIRST COMMERCIAL BATCH OF DNV3837 HAS BEEN SUCCESSFULLY INITIATED.THIS TRIAL WILL BE CONDUCTED AS PART OF AN ACTIVE INVESTIGATIONAL NEW DRUG (IND) AUTHORIZATION AND A RECENTLY UPDATED VERSION OF CLINICAL PROTOCOL.INCLUSION OF FIRST PATIENT IS PLANNED FOR MID-2019. 

Company Quote

0.828
0.018 +2.22%
21 Aug 2019